Evidence map›Paper›PMID 30574150›Full record

ArticleFrontiers in immunology2018

SAG/RBX2 E3 Ubiquitin Ligase Differentially Regulates Inflammatory Responses of Myeloid Cell Subsets.

Xiufang Xiong, Nathan D Mathewson, Hua Li, Mingjia Tan, Hideaki Fujiwara, Haomin Li, Pavan Reddy, Yi Sun

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Protein neddylation and its role in health and diseases.Signal transduction and targeted therapy · 2024
    Review
  7. Article
  8. Neddylation Regulation of Immune Responses.Research (Washington, D.C.) · 2023
    Review
  9. Review
  10. Article
  11. Association Between Neddylation and Immune Response.Frontiers in cell and developmental biology · 2022
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Xiufang XiongInstitute of Translational Medicine, and Cancer Institute of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Nathan D MathewsonDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States.
Hua LiDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States.
Mingjia TanDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States.
Hideaki FujiwaraDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States.
Haomin LiChildren's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Pavan ReddyDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States.
Yi SunInstitute of Translational Medicine, and Cancer Institute of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Michigan United · USUniversity of Michigan–Ann Arbor · USHarvard University · USSylvester Comprehensive Cancer Center · US

Funding

The role of FBXW2 as a novel lung tumor suppressor that cross-talks with oncogenic beta-TrCP and SKP2R01CA156744 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORGAN, MEREDITH A · 2011 to 2020
$3.4M
Targeting antigen presentation to enhance GVL responses after Bone Marrow TransplR01HL090775 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2008 to 2016
$3.4M
Development of novel strategy for treatment of steroid refractory GVHDR01HL128046 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2015 to 2019
$2.1M
Role of SAG/RBX2 E3 Ubiquitin Ligase in Skin CarcinogenesisR01CA171277 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUN, YI · 2013 to 2017
$1.6M
Role of noncoding RNA in Regulating GVHDR01CA173878 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2013 to 2017
$1.6M
NCI NIH HHS R01 CA156744NCI NIH HHS R01 CA171277NCI NIH HHS R01 CA173878NHLBI NIH HHS R01 HL090775NHLBI NIH HHS R01 HL128046
6 · The paper itself

Abstract

Macrophages form an important component of the innate immune system and serve as first responders against invading pathogens. While pathways critical for initiation of inflammatory responses between macrophages and other LysM

Indexed as

AnimalsCell DifferentiationCells, CulturedCytokinesDisease Models, AnimalEscherichia coliEscherichia coli InfectionsFemaleHumansLeukocyte ElastaseLipopolysaccharidesMacrophagesMaleMiceMice, KnockoutMyeloid Progenitor CellsCytokinesLeukocyte ElastaseLipopolysaccharidesPeroxidaseRnf7 protein, mouseUbiquitin-Protein Ligasesinflammatory responseLPSmacrophageneutrophilSAG ubiquitin ligase

Identifiers

PMID30574150
PMCPMC6291737
OpenAlexW2904893711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.